Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. Elamin YY, Robichaux JP, Carter BW, Altan M, et al. J Clin Oncol 2021 Sep 22:JCO2101113. doi: 10.1200/JCO.21.01113.

Read + Share

Amedeo Smart

Independent Medical Education

Elamin YY, Robichaux JP, Carter BW, Altan M, et al. Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. J Clin Oncol 2021 Sep 22:JCO2101113. doi: 10.1200/JCO.21.01113.
PMID: 34550757